Eosinophilia Myalgia Syndrome is a hypereosinophilic disorder that appears
to result from the ingestion of the dietary supplement L-tryptophan by susc
eptible individuals. It is unclear if this disease results from tryptophan,
contaminants found in tryptophan, individual predisposition (such as immun
e status and allergies), or some combination of effects. To evaluate effect
s of L-tryptophan on eosinophil migration, guinea pigs were compared with o
r without supplemental tryptophan (0.4 g/kg/day), with or without immune se
nsitization, and with or without immune challenge. Eosinophil counts were o
btained from bone marrow, blood, lung, and bronchial alveolar lavage fluid
(BAL), Lung cells were obtained to measure eotaxin concentrations in supern
ates and lysates with or without antigen and calcium ionophore challenge us
ing direct ELISA. Skin biopsies were taken from both non-injected and antig
en injection sites. The tryptophan supplemented, antigen-sensitized/antigen
-challenged guinea pigs showed a significant decrease in blood eosinophils,
compared to control (cellulose) supplemented antigen-sensitized/antigen-ch
allenged guinea pigs [(0.086 +/- 0.023) x 10(6) vs (0.147 +/- 0.021) x 10(6
) eosinophils/ml recovered, respectively] with a significant increase in BA
L eosinophils [(0.052 +/- 0.008)x 10(6) vs (0.033 +/- 0.005) x 10(6) eosino
phils/ml recovered, respectively]. Unchallenged lung cell lysates from tryp
tophan-supplemented guinea pigs contained significantly less eotaxin compar
ed to cellulose-supplemented guinea pigs regardless of whether they were se
nsitized (0.006 +/- 0.002 vs 0.027 +/- 0.008 ng/10(6) cells, respectively).
No differences were observed in skin biopsies between cellulose and trypto
phan groups. These results suggest that L-tryptophan-supplemented guinea pi
gs have altered eotaxin regulation, a potential mechanism by which human ov
erconsumption of tryptophan dietary supplements could lead to hypereosinoph
ilic disorders in susceptible individuals.